Evaluation of the Safety and Pharmacokinetics of Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Combination Ophthalmic Solution
Clinical trial NCT05815758 · COMPLETED
Trial details
- NCT number
- NCT05815758
- Sponsor
- Bausch & Lomb Incorporated
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-20
- Primary completion
- 2023-09-18
- Enrollment
- 512
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.